Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: a global mapping of service delivery

[1]  D. Vlahov,et al.  Using nominal group technique to identify barriers and facilitators to preventing HIV using combination same-day pre-exposure prophylaxis and medications for opioid use disorder , 2022, Harm Reduction Journal.

[2]  N. Ford,et al.  Scaling up access to HIV pre-exposure prophylaxis (PrEP): should nurses do the job? , 2022, The lancet. HIV.

[3]  S. Baral,et al.  A Systematic Review of Gender-Based Violence Prevention and Response Interventions for HIV Key Populations: Female Sex Workers, Men Who Have Sex With Men, and People Who Inject Drugs , 2022, Trauma, violence & abuse.

[4]  V. Martel-Laferrière,et al.  Telehealth for people who inject drugs: An acceptable method of treatment but challenging to access , 2022, Journal of addictive diseases.

[5]  J. Dovidio,et al.  An Experimental Study of the Effects of Patient Race, Sexual Orientation, and Injection Drug Use on Providers’ PrEP-Related Clinical Judgments , 2021, AIDS and Behavior.

[6]  S. Friedman,et al.  PrEP Care Continuum Engagement Among Persons Who Inject Drugs: Rural and Urban Differences in Stigma and Social Infrastructure , 2021, AIDS and Behavior.

[7]  C. Estcourt,et al.  Evaluation of an inner city HIV pre‐exposure prophylaxis service tailored to the needs of people who inject drugs , 2021, HIV medicine.

[8]  R. Pollini,et al.  Mobile Phone and Internet Use among People who Inject Drugs: Implications for Mobile Health Interventions , 2021, Substance abuse.

[9]  S. Young,et al.  Potential Effects of Digital Inequality on Treatment Seeking for Opioid Use Disorder , 2021, International Journal of Mental Health and Addiction.

[10]  F. Altice,et al.  Acceptability of an mHealth App That Provides Harm Reduction Services Among People Who Inject Drugs: Survey Study , 2021, Journal of medical Internet research.

[11]  A. Bazzi,et al.  High levels of used syringe use and unsafe sex among people who inject drugs in Kumasi, Ghana: an urgent call for a comprehensive harm reduction approach , 2021, Harm Reduction Journal.

[12]  S. Liang,et al.  Barriers to Care Experienced by Patients Who Inject Drugs During the COVID-19 Pandemic: A Qualitative Analysis , 2021, Journal of addiction medicine.

[13]  A. Cox,et al.  Pre-exposure prophylaxis awareness, acceptability and potential stigma among medical and non-medical clinic staff in methadone treatment settings in northern New Jersey: The key role of non-medical staff in enhancing HIV prevention. , 2021, Journal of substance abuse treatment.

[14]  D. Celentano,et al.  Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: Results from a multi-city cross-sectional survey , 2021, PloS one.

[15]  B. Idrisov,et al.  Violence, HIV Risks, and Polysubstance Use Among HIV-Positive People Who Inject Drugs in Ukraine , 2021, AIDS and Behavior.

[16]  M. D'Eon,et al.  Qualitative assessment of patients’ perspectives and needs from community pharmacists in substance use disorder management , 2020, Substance Abuse Treatment, Prevention, and Policy.

[17]  P. Meylakhs,et al.  Harm reduction via online platforms for people who use drugs in Russia: a qualitative analysis of web outreach work , 2020, Harm Reduction Journal.

[18]  P. Flowers,et al.  Perspectives on pre-exposure prophylaxis for people who inject drugs in the context of an hiv outbreak: A qualitative study. , 2020, The International journal on drug policy.

[19]  J. Pathak,et al.  Healthcare utilization patterns among persons who use drugs during the COVID-19 pandemic , 2020, Journal of Substance Abuse Treatment.

[20]  M. Copenhaver,et al.  The Pre-exposure Prophylaxis (PrEP) Care Cascade in People Who Inject Drugs: A Systematic Review , 2020, AIDS and Behavior.

[21]  S. Braunstein,et al.  The role of syringe exchange programs and sexual identity in awareness of pre-exposure prophylaxis (PrEP) for male persons who inject drugs. , 2020, The International journal on drug policy.

[22]  A. Mirzazadeh,et al.  Dual Unsafe Injection and Sexual Behaviors for HIV Infection Among People Who Inject Drugs in Iran , 2018, AIDS and Behavior.

[23]  A. Roth,et al.  Factors Associated with Awareness of Pre-exposure Prophylaxis for HIV Among Persons Who Inject Drugs in Philadelphia: National HIV Behavioral Surveillance, 2015 , 2018, AIDS and Behavior.

[24]  C. Sykes,et al.  A Pharmacokinetic/Pharmacodynamic Model to Predict Effective HIV Prophylaxis Dosing Strategies for People Who Inject Drugs , 2018, The Journal of Pharmacology and Experimental Therapeutics.

[25]  J. Leung,et al.  Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review , 2017, The Lancet. Global health.

[26]  J. Montaner,et al.  HIV and the criminalisation of drug use among people who inject drugs: a systematic review. , 2017, The lancet. HIV.

[27]  S. Braunstein,et al.  Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: the importance of networks and syringe exchange programs for HIV prevention , 2017, Harm Reduction Journal.

[28]  G. Duarte,et al.  Effectiveness of needle and syringe Programmes in people who inject drugs – An overview of systematic reviews , 2017, BMC Public Health.

[29]  R. Grant,et al.  Effectiveness and safety of oral HIV preexposure prophylaxis for all populations , 2016, AIDS.

[30]  Steffanie A Strathdee,et al.  Factors associated with patterns of mobile technology use among persons who inject drugs , 2016, Substance abuse.

[31]  L. Adams,et al.  HIV providers’ likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short report , 2016, AIDS care.

[32]  C. Bond,et al.  Community pharmacy services for people with drug problems over two decades in Scotland: Implications for future development. , 2016, The International journal on drug policy.

[33]  R. Westergaard,et al.  Uptake and Acceptability of Information and Communication Technology in a Community-Based Cohort of People Who Inject Drugs: Implications for Mobile Health Interventions , 2015, JMIR mHealth and uHealth.

[34]  C. Hendrix,et al.  Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial , 2013, The Lancet.

[35]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[36]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..